| Security | CDNA / CareDx, Inc. |
| Insider | Keith Kennedy |
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Keith Kennedy in CDNA / CareDx, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Keith Kennedy in CDNA / CareDx, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | 2026-04-20 | 4 | Kennedy Keith | CDNA | Common Stock | D | 24,134 | 221,548 | ||||||
| 2026-04-03 | 2026-04-01 | 4 | Kennedy Keith | CDNA | Common Stock | D | 17.8700 | -11,725 | -210 | 197,414 | ||||
| 2026-02-04 | 2026-02-02 | 4 | Kennedy Keith | CDNA | Common Stock | D | 20.4200 | -4,644 | -95 | 209,139 | ||||
| 2026-02-04 | 2026-02-02 | 4 | Kennedy Keith | CDNA | Common Stock | D | 14,474 | 213,783 | ||||||
| 2026-02-04 | 2026-02-02 | 4 | Kennedy Keith | CDNA | Common Stock | D | 60,000 | 199,309 | ||||||
| 2025-09-15 | 2025-09-12 | 4 | Kennedy Keith | CDNA | Common Stock | D | 13.5300 | -7,987 | -108 | 139,309 | ||||
| 2025-03-25 | 2025-03-21 | 4 | Kennedy Keith | CDNA | Common Stock | D | 77,195 | 147,296 | ||||||
| 2024-09-16 | 2024-09-12 | 4 | Kennedy Keith | CDNA | Common Stock | D | 70,101 | 70,101 |
